Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Songling Zhang has a total of 225 co-authors. Here are the top co-authors by number of shared publications:

  • Zhentong Wei

    Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China

    13 shared publications
  • Xinxin Ci

    Institute of Translational Medicine, The First Hospital of Jilin University, Jilin University, Changchun, Jilin, China; Jilin Provincial Key Laboratory of Women's Reproductive Health, Changchun, Jilin, China

    11 shared publications
  • Xiaoling Hong

    Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China

    10 shared publications
  • Mengwen Zhang

    Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China

    8 shared publications
  • Ning Ma

    Department of Obstetrics and Gynecology, The First Hospital of Jilin University, Changchun, China

    8 shared publications
  • Shoujun Zhu

    Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, The First Hospital of Jilin University, Changchun 130021, P. R. China

    7 shared publications

Latest Publications

  • Open Access

    NFE2L1 promotes cisplatin resistance by attenuating ferroptosis through SLC27A2-mediated fatty acid metabolism in ovarian cancer

    by Mengwen Zhang, Shumin Yan, Benzheng Zhao, Ning Ma, Keke Wang, Lin Hou, Si Chen, Mingyue Zhao, Jie Huang, Tong Ren, et al.

    Approaches that promote ferroptosis have emerged as promising therapeutic strategies for chemotherapy-resistant cancers; however, the mechanisms regulating ferroptosis during acquired therapeutic resistance remain incompletely understood. Using RNA sequencing, we identified that Nuclear Factor Erythroid-2 Related Factor 1 (NFE2L1) is upregulated in cisplatin-resistant ovarian cancer (OC) cells and patient tissues, as well as in ferroptosis-resistant models. Genetic knockdown of NFE2L1 resensitized cells to cisplatin both in vitro and in vivo. Notably, this effect was largely reversed by ferroptosis inhibitors, which significantly rescued cell survival following NFE2L1 depletion under cisplatin treatment. Further experiments demonstrated that modulating NFE2L1 expression affects the response to ferroptosis inducers by regulating iron accumulation and lipid peroxidation. Mechanistically, NFE2L1 silencing increased the transcription of long-chain fatty acid transport protein 2 (SLC27A2/FATP2). Chromatin immunoprecipitation and dual-luciferase reporter assays showed that NFE2L1 bound directly to the SLC27A2 promoter, where it competitively inhibited the recruitment of the transcription factor SP1. As a key member of the long-chain acyl-CoA synthetase family, FATP2 promotes the uptake and activation of long-chain fatty acids, processes that have been implicated in the regulation of ferroptosis. Subsequent LC–MS-based lipidomic analysis revealed that NFE2L1 reprogrammed intracellular fatty acid metabolism, characterized by increased polyunsaturated fatty acid (PUFA) levels and decreased monounsaturated fatty acid (MUFA) levels within phosphatidylethanolamines (PEs), thereby increasing cellular susceptibility to ferroptosis. Consistent with these findings, supplementation with exogenous unsaturated fatty acids modulated NFE2L1-mediated ferroptosis sensitivity. Collectively, our findings reveal a novel NFE2L1/SLC27A2 axis that drives cisplatin resistance in OC by suppressing ferroptosis, and suggest a potential therapeutic strategy for treating cisplatin-resistant ovarian cancer.

  • Open Access

    A folate receptor–targeted NIR-II probe improves intraoperative imaging and surgery of metastatic ovarian cancer

    by Wanying Li, Zimu Yuan, Shiqi Bai, Yuewei Zhang, Tianyang Han, Yuhuan Li, Xiaosen Li, Shoujun Zhu, Qi Zhou, Songling Zhang, et al.

    Intraoperative fluorescence imaging holds great promise for achieving complete cytoreduction in ovarian cancer, but its clinical utility is currently constrained by the limitations of existing imaging agents. In particular, the leading clinical probe, OTL38, operates in the near-infrared I (NIR-I; 700 to 1000 nanometers) window, which suffers from limited tissue penetration and suboptimal resolution. Here, a folate receptor α (FRα)–targeted NIR-II (1000 to 3000 nanometers) imaging probe was developed by incorporating a 4-(4-iodophenyl)butanoic acid moiety. This structural modification enables albumin binding, thereby prolonging systemic circulation and enhancing accumulation in FRα-positive tumors. In murine models of peritoneal metastasis, our probe enabled precise visualization of occult lesions undetectable by the naked eye. Compared to OTL38, this probe demonstrated superior tumor detection sensitivity (90.20% versus 78.75%) and allowed for the reliable identification of elusive lesions less than or equal to 3 millimeters in diameter. These findings highlight the potential of albumin-binding NIR-II imaging strategies to overcome the limitations of current clinical probes and enhance precision fluorescence–guided surgery.


  • Open Access

    A NIR fluorotag reporter CETIF6a enables bright pan-tumor labeling and functional proteomic profiling

    by Jia Li, Feiran Zhang, Jianing Cheng, Xu Peng, Cheng Li, Chengbin Zhang, Yuewei Zhang, Songling Zhang, Shoujun Zhu

    Tumor-seeking fluorescent dyes enable precise lesion localization by recognizing overexpressed receptors, providing a critical adjunctive technology for cancer histopathology. However, tumor heterogeneity and the poor understanding of targeting mechanisms limit their efficacy. Here we engineer CETIF6a, a click chemistry-compatible heptamethine cyanine dye, for multi-cancer targeting, intraoperative histopathology, and proteome-wide target identification. CETIF6a demonstrates margin delineation across multiple cancer types ( > 90% concordance with H&E staining). Quantitative proteomics reveals that the dye targets 5-15 times more tumor-specific proteins than in paracancerous tissues. Synergistic pan-cancer targeting is achieved through 491 conserved tumor-enriched proteins involved in ribosomal, proteasomal, and metabolic pathways, effectively overcoming heterogeneity. Mechanistic studies confirm that CETIF6a emits bright fluorescence upon covalent binding to targets via nucleophilic substitution at cysteine thiol residues within hydrophobic cavities. The modifiable scaffold of CETIF6a supports both intraoperative tumor diagnosis and functional targets profiling, providing a foundation for systematic probe optimization.

  • Open Access

    Mechanical regulation of adipogenic reprogramming suppresses ovarian cancer progression

    by Yu-Huan Li, Jia-Wen Zhao, Xin Wang, Zong-Bao Lu, Wei Li, Song-Ling Zhang, Zheng-Quan He

    Epithelial ovarian cancer (EOC) is a lethal malignancy with high recurrence rates owing to residual micrometastases and chemoresistance. This study explores cytoskeletal regulation as a potential therapeutic strategy to modulate tumor cell fate. We demonstrate that combining (‒)-Blebbistatin (Ble) with adipogenic stimuli (BMP4 or PPARγ agonists) effectively induces adipogenic transdifferentiation of ovarian cancer cells both in vitro and in vivo. The transformed cells exhibit characteristic lipid droplet accumulation, upregulated adipogenic markers ( PPARG , CEBPA , and FABP4 ), and functional maturation evidenced by β-adrenergic-responsive lipolysis. In subcutaneous and intraperitoneal models, Ble treatment significantly suppressed tumor growth, with HuNu/Perilipin 1 colocalization confirming human tumor cell conversion into adipocyte-like cells. Mechanistic investigations reveal that cytoskeletal destabilization triggers nuclear heterochromatin redistribution and chromatin decondensation, enhancing accessibility for adipogenic transcription factors ( CEBPA and CEBPB ) to activate related transcriptional programs. The critical role of mechanical signaling is demonstrated by both adipogenic conversion on soft substrates and the prevention of Ble-triggered adipogenesis following overexpression of a constitutive nuclear localization mutant of YAP. These findings establish that cytoskeletal destabilization in combination with adipogenic instructive cues enable the adipogenic reprogramming of EOC cells via heterochromatin remodeling, providing preclinical insights for ovarian cancer differentiation-targeted therapy.


  • Open Access

    AI-assisted case-based learning and flipped classroom to improve clinical decision-making: a randomized controlled trial in reproductive medicine

    by Qi Wang, Cong Hu, Yiyang Li, Ting Zhang, Songling Zhang

    Efficient training of reproductive medicine clinicians is critical in the context of declining global fertility and increasing infertility. Traditional lecture‑based instruction often fails to sufficiently develop clinical decision‑making skills within limited residency rotations. Innovative strategies that integrate artificial intelligence (AI) with case‑based learning (CBL) and flipped classroom (FC) formats may enhance clinical reasoning, however rigorous evidence in reproductive medicine education remains limited. We conducted a randomized controlled trial involving 50 obstetrics and gynecology residents at the First Hospital of Jilin University. Participants were randomly assigned to an AI‑assisted CBL+FC group or a traditional lecture control group. The AI‑assisted CBL+FC group completed pre‑class interactive case work with virtual standardized patients on the DoctorU platform and case analyses on the Superstar Learning platform, followed by interactive in‑class discussions. Primary outcomes included post‑course theoretical knowledge tests, Mini‑Clinical Evaluation Exercise (Mini‑CEX), and Objective Structured Clinical Examination (OSCE) scores. Secondary outcomes assessed learner motivation, clinical thinking, self‑directed learning, and perceived course effectiveness using a 5‑point Likert scale. Baseline characteristics were comparable between groups. After the intervention, the AI‑assisted CBL+FC group achieved significantly higher theoretical test scores than the control group. The AI‑assisted CBL+FC group also demonstrated superior overall clinical competence in Mini‑CEX assessments and higher OSCE total scores. Participants in the AI‑assisted CBL+FC group reported greater improvements in learning motivation, clinical reasoning, self‑directed learning, and perceived course effectiveness. The AI‑assisted CBL+FC instructional model significantly enhances theoretical knowledge, clinical decision‑making skills, and learner engagement among reproductive medicine residents. This blended learning model offers an efficacious and generalizable methodology for training practitioners to address the evolving clinical requirements within contemporary fertility care.


  • Open Access

    PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer

    by Lin Hou, Mengwen Zhang, Weihua Tong, Songling Zhang

    Post-translational modifications (PTMs) play pivotal roles in ovarian cancer pathogenesis, with poly(ADP-ribosyl)ation (PARylation) serving as a key regulator of DNA repair, immune evasion, and therapeutic resistance. Beyond PARylation, diverse PTM networks—including ubiquitination, phosphorylation, acetylation, methylation, and glycosylation—orchestrate signaling cascades that shape tumor progression and immune recognition. Aberrant glycosylation of MUC16 (CA125) and immune checkpoints such as PD-L1 exemplifies how PTMs modulate the tumor immune microenvironment. This review synthesizes current evidence on the interplay between PARylation and other PTM networks in ovarian cancer, with emphasis on their roles in DNA repair, immune modulation, and drug resistance. We discuss PARP1/2-mediated regulation of cGAS/STING signaling and immune cell activity, alongside resistance mechanisms involving EHMT1/2-associated histone methylation, SPINDOC-enhanced PARylation, and ubiquitin-dependent PARP1 stabilization. Therapeutically, we evaluate combinatorial approaches pairing PARP inhibitors with ATR/CHK1 inhibition, immune checkpoint blockade, or metabolic targeting. Emerging strategies combining PARP inhibitors with PRMT, UBA1, WEE1, or MEK inhibitors are examined, alongside recent clinical trials including the GINECO study of bevacizumab, olaparib, and durvalumab. Mechanistic insights into PARP inhibitor-induced T cell DNA damage and strategies to preserve lymphocyte function are also discussed. Preclinical approaches involving nanoparticle delivery, PROTACs, and ferroptosis induction are reviewed for their potential to disrupt PARylation networks. Despite these advances, clinical translation faces substantial challenges, including patient heterogeneity, overlapping toxicities, adaptive resistance through PTM network rewiring, and the need for predictive biomarkers beyond BRCA mutation status. Current obstacles in resolving spatiotemporal PTM dynamics and cancer stem cell-specific vulnerabilities are outlined. This work aims to inform future research on targeting PARylation-associated PTM pathways to overcome ovarian cancer’s evolvable resistance.


  • Open Access

    PARP inhibitors target cellular energy metabolism: Mechanisms of action and clinical implications

    by Jiajia Li, Degong Mu, Jin Li, Maozhuo Lan, Wei Wu, Songling Zhang, Yun Dai


  • Open Access

    Machine Learning‐Enhanced Analysis of Exosomal Surface Sialic Acid Using Surface‐Enhanced Raman Spectroscopy for Ovarian Cancer Diagnosis and Therapeutic Monitoring

    by Lili Cong, Jiaqi Wang, Sijun Huang, Xiaxia Man, Yi Guo, Shuping Xu, Songling Zhang

    Currently, the absence of ovarian cancer (OC)‐specific biomarkers impedes the development of precise noninvasive diagnostic and monitoring strategies. Exosomal surface sialic acid (SA), a key mediator of intercellular communication and disease progression, emerges as a promising biomarker, though its role in OC remains unclear. Conventional exosome isolation and detection methods exhibit limited clinical utility. Herein, we developed a CD63 aptamer‐functionalized gold array chip integrated with a surface‐enhanced Raman scattering (SERS) nanosensor for sensitive SA analysis. The chip efficiently isolated exosomes from clinical serum, while the nanosensor selectively bound exosomal SA via molecular recognition, thereby altering the SERS intensity ratio of the nanosensor. More importantly, machine learning can discern SA signatures from SERS spectra, achieving 93% accuracy in OC diagnosis. The longitudinal monitoring of SA throughout the entire treatment period (preoperative, postoperative, and chemotherapy) revealed a potential correlation with treatment response as indicated by clinical markers (CA125, HE4), demonstrating the utility of exosomal SA in precision treatment evaluation. This provides a powerful tool for the diagnosis and treatment monitoring of OC and plays a critical role in precision medicine.


  • Open Access

    Correction: the promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer

    by Mengwen Zhang, Xiaoling Hong, Ning Ma, Zhentong Wei, Xinxin Ci, Songling Zhang

  • Open Access

    Regulating SLC7A11/GSH/GPX4 axis by glucose dyshomeostasis to simultaneously promote disulfidptosis, cuproptosis and ferroptosis

    by Mengsi Zhang, Hao Zheng, Hao Jin, Xuanqi Zhu, Shuwei Liu, Yang Chen, Hao Zhang, Songling Zhang

    As one of the key targets of tumor metabolic therapy, glucose dyshomeostasis by disrupting glucose metabolism possesses the potential to reverse therapeutic resistance of a variety of regulated cell deaths (RCDs), but the functional pathways are not fully revealed and employed. Herein, we demonstrate that the intervention on SLC7A11/GSH/GPX4 antioxidant axis by glucose dyshomeostasis can simultaneously promote disulfidptosis, cuproptosis and ferroptosis, which is verified by employing glucose oxidase (GOx)-modified copper-apigenin (CuAp) network nanoshuttles (CuAp@GOx NSs) in ovarian tumor therapy. Ap and GOx can jointly induce glucose dyshomeostasis respectively by inhibiting glucose transporter 1-mediated glucose uptake upstream, and consuming massive glucose downstream. As a result of glucose dyshomeostasis, the NADPH supplement is downregulated, which further disrupts SLC7A11/GSH/GPX4 antioxidant axis. This simultaneously boosts disulfidptosis by facilitating cystine accumulation, cuproptosis by attenuating GSH-mediated Cu+ inactivation, and ferroptosis by downregulating GPX4 expression. Owing to the combination of disulfidptosis, cuproptosis and ferroptosis, CuAp@GOx NSs exhibit good efficacy in treating ovarian tumor model. This work proposes an alternative strategy for tumor therapy based on glucose dyshomeostasis, which mainly targets the RCDs relating to SLC7A11/GSH/GPX4 axis.